CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 231 enrolled
Drug / intervention
Patient counseling for HCV associated CVD risk factorsbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03402334
NCT03402334N/ACompleted
CompareCT.gov

Assessing Healthcare Outcomes of Hepatitis C Virus (HCV) Positive Patients Counseled for Cardiovascular Disease Risk Factors

Tulane University·interventional·Posted Jan 18, 2018·Updated Sep 21, 2022

In Brief

A clinical study evaluating Patient counseling for HCV associated CVD risk factors for Hepatitis C and Atherosclerosis. Completed, enrolled 231 participants across 1 site.

Detailed Summary

The study aims to compare the effect of a cardiovascular education package intervention on treatment-seeking behavioral outcomes of HCV+ patients. This prospective multicenter trial will compare outcomes between the intervention group (HCV+ patients receiving the enhanced education package) and the control group (HCV+ patients receiving the standard of care, the basic education package). The primary outcome measured will be successful linkage to hepatology for a discussion of HCV treatment options. The secondary outcome measured will be linkage to primary care for chronic disease management.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis C, Atherosclerosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJan 18, 2018
Enrollment StartMar 11, 2019
Primary CompletionFeb 15, 2021
Study CompletionApr 30, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 8.5 years ago

Interventions

Patient counseling for HCV associated CVD risk factorsbehavioral

Patients will be counseled for cardiovascular disease risk factors associated with Hepatitis C infection. Such risk factors include atherosclerosis, heart attack, and stroke. Cardiovascular risk factors can be managed through connection with primary care and reduced through curative HCV treatment.